Skip to main content
. 2022 May 23;12:900203. doi: 10.3389/fonc.2022.900203

Figure 5.

Figure 5

Association between m7Gscore and clinicopathological factors. (A–H) The distribution of m7Gscores according to pathological T stage (A), N stage (B), Gleason score (C), PSA (D), age (E), tumor status (F), SMS (G), and primary therapy outcome (H). (I, J) Verification of the characteristics of m7Gscore to be an independent BCR-free prognostic index with the univariate (I) and multivariate (J) Cox regression analyses. PSA, prostate-specific antigen; SMS, surgical margin status; BCR, biochemical recurrence. *p < 0.05; ***p < 0.001. ns, no significance.